ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,895.95
-0.28%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.00%
Brent Oil
83.76
0.00%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. BetterLife Pharma Inc (QB) (BETRF)

  7. BetterLife Pharma Inc (QB) (BETRF) ニュース

BETRF

BetterLife Pharma (QB) (BETRF)

BetterLife Pharma Inc (QB)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:BETRF
日付受信時刻ニュースソース見出しコード企業名
2024/05/1505 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2024/05/0622 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2024/03/0605 : 41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2024/01/0303 : 37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/12/3004 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/12/1902 : 13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/12/0103 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/09/3002 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/09/2822 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/09/0523 : 58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/07/1400 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/06/2906 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/06/2906 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/06/2906 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BETRFBetterLife Pharma Inc (QB)
2023/06/1005 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/06/0705 : 23Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/05/1022 : 00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/04/2602 : 35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/03/0904 : 24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/03/0806 : 31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/02/2823 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2023/01/1823 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/12/2323 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/12/0822 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/11/0907 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/09/2805 : 31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/06/3002 : 22Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/06/0703 : 35Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/06/0119 : 00Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)USOTC:BETRFBetterLife Pharma Inc (QB)
2022/03/0503 : 21Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:BETRFBetterLife Pharma Inc (QB)
 Showing the most relevant articles for your search:USOTC:BETRF

最近閲覧した銘柄

ASX
EMPDD
Emperor Energy
TSX
DTOL
D2L
ASX
EGF
Evans and Partners Globa...
NYSE
CLB
Core Laboratories
BOV
JALL3Q
Jalles Machado ON
NYSE
WFT
Weatherford
ASX
ERLNA
Empire Resources
BOV
JFEN1
JOAO FORTES ON
NYSE
TAC
TransAlta
NASDAQ
SWSI
BOV
JFEN3
JOAO FORTES ON
NYSE
SA
Seabridge Gold
ASE
ALPHA
Alpha Services
NASDAQ
MDAIW
Spectral AI
NYSE
RES
RPC
ASX
ETRO
Entyr
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有